[ad_1] NEW YORK, Aug. 17, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of DexCom, Inc. (“DexCom” or the “Company”) (NASDAQ: DXCM). Such investors are advised to contact Danielle Peyton at [email protected] or […]
Insights and updates
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sage Therapeutics, Inc.
[ad_1] NEW YORK, Aug. 17, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Sage Therapeutics, Inc. (“Sage” or the “Company”) (NASDAQ: SAGE). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. […]
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of STMicroelectronics N.V.
[ad_1] NEW YORK, Aug. 17, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of STMicroelectronics N.V. (“ST” or the “Company”) (NYSE: STM). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, […]
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MaxLinear, Inc.
[ad_1] NEW YORK, Aug. 17, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of MaxLinear, Inc. (“MaxLinear” or the “Company”) (NASDAQ: MXL). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, […]
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Allarity Therapeutics, Inc.
[ad_1] NEW YORK, Aug. 17, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR). Such investors are advised to contact Danielle Peyton at [email protected] or […]
